Yeasts

SCYNEXIS Announces FDA Approval of BREXAFEMME® (ibrexafungerp tablets) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections

Retrieved on: 
Wednesday, June 2, 2021
Branches of biology, Medical specialties, Infectious diseases, Yeasts, Gut flora, Pathogenic microbes, Cándida, Vaginal yeast infection, Candidiasis, VVC, Antifungal, Chloroarenes

The FDA approval of BREXAFEMME is the culmination of years of work and a significant milestone for SCYNEXIS, marking our evolution to a commercial-stage antifungal company.

Key Points: 
  • The FDA approval of BREXAFEMME is the culmination of years of work and a significant milestone for SCYNEXIS, marking our evolution to a commercial-stage antifungal company.
  • BREXAFEMME has a differentiated fungicidal mechanism of action that kills a broad range of Candida species, including azole-resistant strains.
  • BREXAFEMME is the trade name for ibrexafungerp, a novel oral antifungal approved for the treatment of vulvovaginal candidiasis (VVC), also known as vaginal yeast infection.
  • BREXAFEMME represents the first approved drug in a new antifungal class in over 20 years and is the first and only treatment for vaginal yeast infections which is both oral and non-azole.

Gnosis by Lesaffre Enhances Vitamin K2 Offering with Acquisition of NattoPharma

Retrieved on: 
Tuesday, May 25, 2021
Science, Research, Pharmaceutical, Health, Specialty, Food, Beverage, Fitness & Nutrition, Retail, Nutrition, Landforms, Vitamin K, Lesaffre, Yeasts, Weapons, GNOSIS, Vitamin, Daewoo Precision Industries K2, K2

Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma, another renowned supplier.

Key Points: 
  • Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma, another renowned supplier.
  • View the full release here: https://www.businesswire.com/news/home/20210525006000/en/
    Gnosis by Lesaffre is expanding its capability as a global supplier of vitamin K2 with its acquisition of NattoPharma.
  • Gnosis by Lesaffre will share more details about the strategic growth of the vitamin K2 market over the coming months as the acquisition is finalized.
  • Based in Norway, NattoPharma ASA is the world leader in vitamin K2 research and development, offering the only clinically validated K2 as MK-7 on the market: MenaQ7.

Lunar Launches Limited Edition Heritage Line in Collaboration with Di An Di and 886

Retrieved on: 
Tuesday, May 18, 2021
Food and drink, Foods, Yeasts, Baker's yeast, Breads, Edible fungi, Fermentation in food processing, Pineapple cake, Drink

This flavor is inspired by Taiwan\'s most popular delicacy, the pineapple cake, or feng li su .

Key Points: 
  • This flavor is inspired by Taiwan\'s most popular delicacy, the pineapple cake, or feng li su .
  • A portion of proceeds will be donated to the chefs who created the recipes and Apex For Youth.
  • Lunar uses a proprietary yeast and nutrient blend coupled with a filtration process that results in the uncompromised quality of the brand\'s seltzers.
  • To learn more about Lunar, head over to their website, http://www.drinklunar.com .\n'

York Ag Features Hilyses, a Natural Yeast Additive, on Its New Website

Retrieved on: 
Monday, April 19, 2021
Food and drink, Leavening agents, Fermentation in food processing, Food additives, Yeasts, Foods, Edible fungi, Fungi, Baker's yeast

http://www.yorkag.com/hilyses\nAs the exclusive U.S. distributor of Hilyses, York Ag decided to increase visibility nationwide for the sought-after yeast-based additive.

Key Points: 
  • http://www.yorkag.com/hilyses\nAs the exclusive U.S. distributor of Hilyses, York Ag decided to increase visibility nationwide for the sought-after yeast-based additive.
  • To survive this harsh environment, Hilyses yeast cells forge tough cell walls denser than those available in conventional yeast cultures.
  • And with no additional carriers, Hilyses delivers the highest concentration of yeast components to the gut.
  • Headquartered in York, Pennsylvania, York Ag commercializes its proprietary products YORK CALCIUM CHIPS, BOVAZYME, and BOVAZYME Organic, and carries a wholesome portfolio of national and international brands from diverse feed ingredient manufacturers.\n'

SKOUT’S HONOR RELEASES BREAKTHROUGH STUDY THAT SCIENTIFICALLY PROVES THE EFFICACY OF ITS PROBIOTIC SKIN CARE LINE FOR PETS

Retrieved on: 
Monday, April 5, 2021
Medical specialties, Branches of biology, Bacteriology, Digestive system, Clinical medicine, Probiotic, Yeasts, Gut flora, Microorganism, Dermatophytosis, Cándida

Skout's proprietary and patent-pending probiotic blend has now been scientifically proven to stop and prevent the growth of Candida and Ringworm - two microbes commonly associated with pet skin ailments, including itch, odor, shedding, hotspots and inflammation.

Key Points: 
  • Skout's proprietary and patent-pending probiotic blend has now been scientifically proven to stop and prevent the growth of Candida and Ringworm - two microbes commonly associated with pet skin ailments, including itch, odor, shedding, hotspots and inflammation.
  • The probiotic blend effectively created a zone of inhibition in a laboratory study conducted by an independent third party, out-performing a common antimicrobial surface treatment by up to 30 percent.
  • This study ultimately signifies a major breakthrough in the natural pet care and skin/coat category by providing a preventative measure for the most common pet skin conditions.
  • Launched in 2017, Skouts Honors Probiotic product line contains live, colony-forming probiotic kefir culture.

Rise Against Hunger Launches 'It Starts With a Meal' Campaign Sponsored by Red Star Yeast

Retrieved on: 
Monday, February 22, 2021
Yeasts, Food and drink, Leavening agents, Articles, Baker's yeast, Breads, Edible fungi, Fermentation in food processing, Lesaffre, Rise Against Hunger, Red Star Yeast, Hunger

"Taking action to help end hunger has never been more important, and It Starts With a Meal gives new ways to do so.

Key Points: 
  • "Taking action to help end hunger has never been more important, and It Starts With a Meal gives new ways to do so.
  • It supports Rise Against Hunger's work to address food and nutrition insecurity through immediate action that leads to sustainable solutions."
  • "Red Star Yeast is committed to supporting those facing hunger," says Bill Hanes, Vice President, Marketing & Strategy of Lesaffre Corporation.
  • Its product brands include Red Star, Platinum Superior Baking Yeast from Red Star, and Saf-Instant.

Global Yeast Ingredients Market Report 2020: Key Players are Archer Daniels Midland, Associated British Foods, Cargill, Kerry Group, & Lesaffre Group - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 11, 2021
Food, Beverage, Retail, Food and drink, Articles, Food additives, Medicinal fungi, Foods, Yeasts, Yeast extract, Analytics, Beta-glucan

The "Yeast Ingredients - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Yeast Ingredients - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Yeast Extract, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$1.3 Billion by the end of the analysis period.
  • In the global Yeast Beta-glucan segment, USA, Canada, Japan, China and Europe will drive the 5% CAGR estimated for this segment.
  • The report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021.

Global Yeast Extract Market (2020 to 2026) - by Technology, Application, Form and Region - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 2, 2021
Food, Beverage, Retail, Food and drink, Foods, Yeasts, Leavening agents, Components, Fermentation in food processing, Edible fungi, Yeast extract, Food additives, Baker's yeast

The Global Yeast Extract Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 4.2% CAGR during the forecast period.

Key Points: 
  • The Global Yeast Extract Market size is expected to reach $1.7 billion by 2026, rising at a market growth of 4.2% CAGR during the forecast period.
  • Yeast extract comprises cell contents of yeast that lack the cell wall.
  • Yeast extract is the common name for thick brown partly solid processed yeast products that are obtained from extracts of the cell content.
  • There are many additional features of yeast extract like it is also Kosher, Halal, GMO-free, and usually does not comprise gluten.

North America Yeast Extract Market 2020-2026 with Profiles of Lallemand, Angel Yeast, Lesaffre Among Others

Retrieved on: 
Tuesday, December 29, 2020
Food and drink, Foods, Fermentation in food processing, Yeasts, Leavening agents, Food additives, Yeast extract, Flavor, Baker's yeast, Taste

Yeast extract is characterized under natural ingredients that have a taste of its own and are used as flavouring agents substituting synthetic additives.

Key Points: 
  • Yeast extract is characterized under natural ingredients that have a taste of its own and are used as flavouring agents substituting synthetic additives.
  • The main properties of these products include taste enhancement ability, ability to partially replace salt, and creates savory flavor.
  • Yeast extract is commonly named for the processed yeast product that is a thick browny semi-solid food prepared by extracting the cellular content by removing the cell wall.
  • Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

Ibrexafungerp, Formerly SCY-078: The First Representative of a Novel Class of Structurally-distinct Glucan Synthase Inhibitors, Triterpenoids - Emerging Insights and Market Forecasts 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 23, 2020
Health, Pharmaceutical, Medical specialties, Branches of biology, Medicine, Pathogenic microbes, Yeasts, Sepsis, Fungemia, Cándida, Multiple drug resistance

"IBREXAFUNGERP- Emerging Insight and Market Forecast - 2030" the report provides comprehensive insights about an investigational product for Candidemia in 7 Major Markets.

Key Points: 
  • "IBREXAFUNGERP- Emerging Insight and Market Forecast - 2030" the report provides comprehensive insights about an investigational product for Candidemia in 7 Major Markets.
  • Further, it also consists of future market assessments inclusive of the market forecast, SWOT analysis, market competitors, and other emerging therapies.
  • Ibrexafungerp (formerly SCY-078) is the first representative of a novel class of structurally-distinct glucan synthase inhibitors, triterpenoids.
  • It has shown activity against Aspergillus and Candida, including against multidrug-resistant (MDR) species Candida auris as well as Pneumocystis.